单孔腹腔镜直肠内拖出术治疗先天性巨结肠的前瞻性研究及系统评价与Meta分析
本研究前瞻性纳入93例先天性巨结肠患儿行单孔腹腔镜直肠内拖出术(SILEP),并系统评价9项研究共420例患者。SILEP平均手术时间70.0±30.3分钟,无中转开腹,小肠结肠炎发生率16.1%,≥4岁患儿84%排便功能良好,瘢痕评分5.73±1.38。SILEP安全有效且美容效果优越。
要点
- SILEP术后小肠结肠炎发生率16.1%,与Meta分析汇总的12%相当。
- ≥4岁患儿中84%获得良好至优秀排便功能评分。
- 平均手术时间70.0±30.3分钟,无术中并发症或中转。
核心结论
- SILEP是治疗先天性巨结肠安全、有效且美容效果优越的术式,围手术期和功能结果良好。
研究设计与样本
- 前瞻性单中心研究纳入2020至2021年93例先天性巨结肠患儿行SILEP,并遵循PRISMA进行系统评价与Meta分析,汇总9项研究420例患者。
主要发现
- 平均手术时间70.0±30.3分钟,显著短于Meta分析汇总估计166.44分钟(95%CI 137.74-195.14,p<0.001)。
- 无术中并发症或中转,平均住院5.23±2.69天。
- 小肠结肠炎发生率16.1%,与汇总估计12%(95%CI 7-21%)相当。
- ≥4岁患儿(n=64)中84%排便功能评分为良好至优秀,平均曼彻斯特瘢痕评分5.73±1.38。
临床怎么用
- SILEP可作为先天性巨结肠的可行替代术式,兼具良好围手术期结果与美容优势。
局限性
- 单中心前瞻性研究,长期安全性及功能结局证据仍有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-incision laparoscopic endorectal pull-through (SILEP) has emerged as an alternative to conventional laparoscopic surgery for Hirschsprung disease (HSCR), offering improved cosmetic outcomes with comparable efficacy. However, its adoption remains limited, and evidence supporting its long-term safety and functional outcomes is sparse. This study presents our institutional experience with SILEP, alongside a systematic review and meta-analysis evaluating perioperative outcomes, postoperative complications, bowel function, and cosmesis. PATIENTS AND METHODS: A prospective study was conducted at our institution involving 93 pediatric patients diagnosed with HSCR, who underwent SILEP between 2020 and 2021. Demographic data, perioperative details, and postoperative outcomes, including bowel function score (Rintala) and cosmetic results (Manchester Scar Scale), were prospectively collected and analyzed. Additionally, a systematic review and meta-analysis were performed following PRISMA guidelines, pooling data from nine studies comprising 420 patients. RESULTS: The mean operative time was 70.0 ± 30.3 min, significantly shorter than the pooled estimate from the meta-analysis (166.44 min; 95% CI 137.74-195.14, p < 0.001). No intraoperative complications or conversions were recorded. The mean hospital stay was 5.23 ± 2.69 days, consistent with prior reports. Enterocolitis occurred in 16.1% of cases, comparable to the pooled estimate (12%; 95% CI 7-21%). Among patients aged ≥ 4 years (n = 64), 84% achieved good to excellent bowel function scores. The mean Manchester Scar Score was 5.73 ± 1.38. CONCLUSION: SILEP is a safe, effective, and cosmetically superior approach for HSCR, with favorable perioperative outcomes and functional results. Our findings, supported by meta-analysis data, reinforce the feasibility of SILEP as a viable alternative for HSCR management.
引用
- Pham HD, Dao DD, Tran QA, et al. Single-incision laparoscopic endorectal pull-through for Hirschsprung disease: a prospective institutional study and systematic review with meta-analysis. Surg Endosc. 2025. PMID: 41023221. doi:10.1007/s00464-025-12114-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。